AMPHAmphastar Pharmaceuticals, Inc.

AMPH Stock Price, Valuation & Chart | Amphastar Pharmaceuticals, Inc.

$23.740+0.78 (+3.40%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic AMPH intrinsic value AMPH calculated fair value vs price

Overview Financials Dividends Ratios

AMPH Historical price chart

AMPH Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.05B

PE Ratio8.1

EPS2.93

Trading Volume436.68K

Today's High/Low23.82/23.03

Dividend Yield0.00

52 Week High/Low31.1/16.65

Shares Outstanding44.09M

AMPH Financial Statement

AMPH Analyst ratings

AMPH Analysis & performance metrics

AMPH Company profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal…

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the…

AMPH Management team

Name

Position

Ziping Luo Ph.D.COO

Chairman of the Board, Chief Scientist & Chief Operating Officer

Yongfeng Zhang Ph.D.CEO

Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Director

William J. Peters M.B.A.CFO

Chief Financial Officer, Executive Vice President of Finance, Treasurer & Director

Tony Marrs M.B.A., M.P.H., M.S.

Executive Vice President of Regulatory Affairs & Clinical Operations

Rong Zhou M.S.

Senior EVice President of Production & EVP of Scientific Affairs

Dan Dischner M.B.A.

Senior Vice President of Human Resources & Corporate Communication

Jacob Liawatidewi M.B.A.CTO

Executive Vice President of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director

Name

Position

Ziping Luo Ph.D.COO

Chairman of the Board, Chief Scientist & Chief Operating Officer

Yongfeng Zhang Ph.D.CEO

Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Director

William J. Peters M.B.A.CFO

Chief Financial Officer, Executive Vice President of Finance, Treasurer & Director

Tony Marrs M.B.A., M.P.H., M.S.

Executive Vice President of Regulatory Affairs & Clinical Operations

Rong Zhou M.S.

Senior EVice President of Production & EVP of Scientific Affairs

Dan Dischner M.B.A.

Senior Vice President of Human Resources & Corporate Communication

Jacob Liawatidewi M.B.A.CTO

Executive Vice President of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director

Management Team

Ziping Luo Ph.D.COO

Chairman of the Board, Chief Scientist & Chief Operating Officer

Yongfeng Zhang Ph.D.CEO

Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Director

William J. Peters M.B.A.CFO

Chief Financial Officer, Executive Vice President of Finance, Treasurer & Director

Tony Marrs M.B.A., M.P.H., M.S.

Executive Vice President of Regulatory Affairs & Clinical Operations

Rong Zhou M.S.

Senior EVice President of Production & EVP of Scientific Affairs

Dan Dischner M.B.A.

Senior Vice President of Human Resources & Corporate Communication

Jacob Liawatidewi M.B.A.CTO

Executive Vice President of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director

Management

Ziping Luo Ph.D.COO

Chairman of the Board, Chief Scientist & Chief Operating Officer

Yongfeng Zhang Ph.D.CEO

Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Director

William J. Peters M.B.A.CFO

Chief Financial Officer, Executive Vice President of Finance, Treasurer & Director

Tony Marrs M.B.A., M.P.H., M.S.

Executive Vice President of Regulatory Affairs & Clinical Operations

Rong Zhou M.S.

Senior EVice President of Production & EVP of Scientific Affairs

Dan Dischner M.B.A.

Senior Vice President of Human Resources & Corporate Communication

Jacob Liawatidewi M.B.A.CTO

Executive Vice President of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director

Total 7 executives

AMPH Frequently asked questions

What is Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price?

Current stock price of Amphastar Pharmaceuticals, Inc. (AMPH) stock is $23.740. The stock price is +3.40% higher in the session. The intraday range can be seen from this page. Volume of Amphastar Pharmaceuticals, Inc. (AMPH) stock is 436.68K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Amphastar Pharmaceuticals, Inc. (AMPH) stock price going up or down today?

The stock price of Amphastar Pharmaceuticals, Inc. (AMPH) can change with earnings, company news, and overall market sentiment. Amphastar Pharmaceuticals, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Amphastar Pharmaceuticals, Inc. stock expensive at its current price?

Whether Amphastar Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AMPH on this page is 8.10. EPS on this page is 2.93. Compare those figures with peers and growth expectations before deciding if the current Amphastar Pharmaceuticals, Inc. price is justified.

How has the stock price of Amphastar Pharmaceuticals, Inc. (AMPH) performed historically?

Historical performance for Amphastar Pharmaceuticals, Inc. (AMPH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AMPH reacted to past earnings and market events.

Should I buy Amphastar Pharmaceuticals, Inc. (AMPH) stock, at this price?

Buying Amphastar Pharmaceuticals, Inc. (AMPH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.